Why should splenic artery aneurysms be repaired prior to liver transplantation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Splenic Artery Aneurysms Should Be Repaired Before Liver Transplantation to Prevent Fatal Rupture

Splenic artery aneurysms (SAAs) in liver transplant candidates must be treated prior to transplantation, regardless of size, due to the high risk of post-transplant rupture and associated mortality of up to 50%. 1

Why Repair is Critical

The hemodynamic changes following liver transplantation dramatically increase rupture risk. When portal pressure normalizes after transplant, the sudden circulatory alterations create mechanical stress on pre-existing SAAs, making rupture significantly more likely in the perioperative period 1, 2. In untreated patients, post-transplant rupture occurs in approximately 4.7% of cases, with a 50% mortality rate when rupture occurs 1.

Key Risk Factors in Transplant Candidates

  • Portal hypertension from cirrhosis is the primary driver of SAA formation in this population 3, 2
  • SAAs occur in approximately 3.8% of liver transplant recipients 3
  • Most aneurysms are located at the splenic hilum (59.2%) with 66% being solitary 3
  • Duration of portal hypertension >10 years substantially increases risk 2

Treatment Algorithm

The choice between surgical ligation versus endovascular embolization depends on SAA location, number, and accessibility 3:

Surgical Ligation (Preferred for):

  • Proximal splenic artery aneurysms
  • Single, accessible lesions
  • Can be performed at time of transplant
  • Lower splenic infarction rate compared to embolization 3

Endovascular Embolization (Preferred for):

  • Distal or intrahilum SAAs (80% of cases) 1
  • Multiple aneurysms
  • Intrasplenic locations
  • Patients with prohibitive surgical risk

Treatment Outcomes and Safety

A 2025 study of 88 transplant recipients with SAAs demonstrated that aggressive pre-transplant treatment (58% surgical, 42% endovascular) resulted in zero SAA-related mortality over 53 months of follow-up 3. While splenic infarction occurred in 75% of treated patients, this complication required no additional invasive intervention and was significantly lower with surgical ligation 3.

Common Pitfall to Avoid

SAAs can be missed on standard imaging. Doppler ultrasound and venous-phase CT cannot reliably distinguish SAAs from splenic varices in patients with extensive portal collaterals 4. Dedicated arterial-phase CT angiography or hepatic angiography is essential for pre-transplant screening in patients with long-standing portal hypertension 4, 2.

Clinical Implementation

Screen all transplant candidates with:

  • >10 years of portal hypertension 2
  • Arterial-phase CT angiography (not venous phase alone) 4

Treat all identified SAAs before transplant, as the traditional 2 cm size threshold used in the general population does not apply to transplant candidates 1, 5. The post-transplant hemodynamic changes make even smaller aneurysms high-risk 1.

References

Research

Treatment algorithm for the management of concomitant splenic artery aneurysms in adult liver transplant recipients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2025

Research

Visceral artery aneurysms: review of current management options.

The Mount Sinai journal of medicine, New York, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.